{"resourceType":"ImplementationGuide","id":"hl7.fhir.us.pq-cmc-fda","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"brr"}],"url":"http://hl7.org/fhir/us/pq-cmc-fda/ImplementationGuide/hl7.fhir.us.pq-cmc-fda","version":"1.1.3","name":"FHIR_pqcmc_fda","title":"Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA","status":"active","publisher":"HL7 International / Biomedical Research and Regulation","contact":[{"name":"HL7 International / Biomedical Research and Regulation","telecom":[{"system":"url","value":"http://www.hl7.org/Special/committees/rcrim"},{"system":"email","value":"brr@lists.HL7.org"}]}],"description":"The FDA PQ-CMC FHIR IG is for submission of structured and standardized information regarding drug product quality, chemistry, manufacturing and processes controls.\u00a0 This data is intended for submission to the US FDA by biopharmaceutical companies for the purpose of drug application review.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US","display":"United States of America"}]}],"packageId":"hl7.fhir.us.pq-cmc-fda","license":"CC0-1.0","fhirVersion":["5.0.0"],"dependsOn":[{"id":"hl7_terminology_r5","uri":"http://terminology.hl7.org/ImplementationGuide/hl7.terminology","packageId":"hl7.terminology.r5","version":"5.5.0"}],"definition":{"resource":[{"reference":{"reference":"SubstanceDefinition/278736ef-2ddf-49e4-895c-3a9f34db36cf"},"name":"278736ef-2ddf-49e4-895c-3a9f34db36cf","description":"The Excipient Raw representing Cochineal","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"Bundle/32532fe8-1bfb-4a0a-998d-9294742a9519"},"name":"32532fe8-1bfb-4a0a-998d-9294742a9519","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32s3"},{"reference":{"reference":"Organization/37a26b1a-ede3-4677-943e-72b513f945b7"},"name":"37a26b1a-ede3-4677-943e-72b513f945b7","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"Organization/48beec35-843c-42f5-9251-7aa6fd693199"},"name":"48beec35-843c-42f5-9251-7aa6fd693199","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"SubstanceDefinition/55f2bbea-1a2d-4240-aef0-bc1a76b39212"},"name":"55f2bbea-1a2d-4240-aef0-bc1a76b39212","description":"Impurity substance for DIOXANE","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-substance-impurity"},{"reference":{"reference":"SubstanceDefinition/58ae52aa-c81e-415a-8791-e67a3195290d"},"name":"58ae52aa-c81e-415a-8791-e67a3195290d","description":"Impurity substance - DICHLOROMETHANE","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-substance-impurity"},{"reference":{"reference":"MedicinalProductDefinition/6248d2ea-c9e0-4280-9beb-08b7041071c2"},"name":"6248d2ea-c9e0-4280-9beb-08b7041071c2","description":"Drug Product with Impurities for AmphetamineSalt_1","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-with-impurities"},{"reference":{"reference":"Bundle/7cdbb042-9275-4599-a1fe-08877846bf94"},"name":"7cdbb042-9275-4599-a1fe-08877846bf94","description":"FHIR document bundle with the CMC eCTD SP4151 profile for an Excipient","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-sp4151"},{"reference":{"reference":"SubstanceDefinition/7f7c63b0-8ad8-4529-b000-bf4b6c384558"},"name":"7f7c63b0-8ad8-4529-b000-bf4b6c384558","description":"Impurity Substance - methylamine","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-substance-impurity"},{"reference":{"reference":"SubstanceDefinition/8202d18a-df68-4cbd-912d-59c7cff5cfa6"},"name":"8202d18a-df68-4cbd-912d-59c7cff5cfa6","description":"Impurity Substance - elementalIron","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-substance-impurity"},{"reference":{"reference":"Organization/98effc99-db2b-428d-89aa-0ce426e02788"},"name":"98effc99-db2b-428d-89aa-0ce426e02788","description":"Sponsor example for eCTD SP4151","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"Bundle/9e8f2d16-66b1-47ec-878d-f50ae021985b"},"name":"9e8f2d16-66b1-47ec-878d-f50ae021985b","description":"FHIR document bundle with the CMC eCTD 32P55 profile for a Drug Product","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p55"},{"reference":{"reference":"MedicinalProductDefinition/5772a6f2-cde1-4903-bfcf-1639340205cc"},"name":"A DrugProductDescription for a multilayer product","description":"An example of section 3.2.P.1.1","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-description"},{"reference":{"reference":"ManufacturedItemDefinition/a8316fc9-8ca8-4115-81c1-9f8f84c99149"},"name":"A FinishedProduct profile based on ManufacturedItemDefinition","description":"An example of section 3.2.P.1.3 for a multilayer product","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-product-part"},{"reference":{"reference":"PlanDefinition/aa514363-d43f-4052-b44e-b67aa4d6dee7"},"name":"A quality specification is for a drug product","description":"A quality specification is for a Drug Product","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-quality-specification"},{"reference":{"reference":"PlanDefinition/cc82a0ce-b72f-4d58-8ea0-6f323e2a9a93"},"name":"A quality specification is for a drug substance","description":"A quality specification is for an API ","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-quality-specification"},{"reference":{"reference":"Bundle/a7a2d35b-5d9d-4a8c-b012-d04a07662c0a"},"name":"a7a2d35b-5d9d-4a8c-b012-d04a07662c0a","description":"An Example FHIR Bundle containing data for the CMC eCTD 32P55 document","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p55"},{"reference":{"reference":"SubstanceDefinition/ac7ac2da-df69-4ed9-b399-4dc40a71b332"},"name":"ac7ac2da-df69-4ed9-b399-4dc40a71b332","description":"Impurity Substance - Phenylacetone","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-substance-impurity"},{"reference":{"reference":"StructureDefinition/pq-additional-info-extension"},"name":"Additional Information","description":"Any additional information","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-amount-ratio"},"name":"Amount Ratio","description":"represent an amount as a ratio in ManufacturedItemDefinition","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-graphic-attachment"},"name":"Analysis Graphic","description":"Any attached file that contains a graphical representation","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-analytical-intstrument-data"},"name":"Analytical Instrument Data","description":"Any attached file that contains analytical instrument data","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-analytical-instrument-data-types"},"name":"Analytical Instrument Data File Types","description":"The acceptable file types that can be used in Analytical Instrument Data Files","exampleBoolean":false},{"reference":{"reference":"DocumentReference/22bd989e-8056-494f-9bc1-195d13428179"},"name":"Base64 Document Reference - L-thyroxine-3D-structure-CT1000583834.sdf","description":"An attached SDfile.  The ASCII file content is attached in base64.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-structure-reference"},{"reference":{"reference":"DocumentReference/d94ad7ac-b935-432f-bc68-312b6b8dcca7"},"name":"Base64 Document Reference - Levothyroid.png","description":"Base 64 Document - png file","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-graphic-reference"},{"reference":{"reference":"DocumentReference/0382d6b1-b656-4e9a-b5c8-9110c4d3f6b3"},"name":"Base64 Document Reference - Monosodium_D-thyroxine_hydrate.png","description":"Monosodium D-thyroxine hydrate.png","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-graphic-reference"},{"reference":{"reference":"StructureDefinition/cmc-organization"},"name":"Basic Organization","description":"A profile for the data elements required to identify the sponsor of the drug products or substances, Suppliers.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-batch-formula-product"},"name":"Batch Formula Drug Product Identification","description":"The Drug Product produced by the batch formula.","exampleBoolean":false},{"reference":{"reference":"MedicinalProductDefinition/d0d2df25-5cfa-4417-b8d1-b8147957f53c"},"name":"Batch Formula Drug Product Identification","description":"Basic idenfier informion in MDI for the Drug Product with reference to the Batch Formula","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-batch-formula-product"},{"reference":{"reference":"ManufacturedItemDefinition/249ef22b-d521-4304-a388-6b9035f97b22"},"name":"Batch Formula for Oxazepam / Propranolol-Hydrochloride product","description":"Batch Formula Exmample for a liquid drug product","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-product-batch-formula"},{"reference":{"reference":"ValueSet/pqcmc-batch-utilization-terminology"},"name":"Batch utilization Terminology","description":"Terminology used to qualify the information pertaining to batch utilization in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"Bundle/30536c0e-456c-4f90-9f02-da7be1d289e9"},"name":"Bundle for 3.2.S.1","description":"Bundle containng nomenclature and molecular structure","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32s10"},{"reference":{"reference":"ValueSet/capsule-classification-category"},"name":"Capsule Shell Classification  Terminology","description":"A category of terminology used to qualify the information pertaining to the classification of a capsule in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"PlanDefinition/ab241f8c-d21e-4382-a70a-52190dbdf07e"},"name":"Carrageenan specification Example","description":"Example raw material (Carrageenan) specification for CTD 3.2.S.2.3.  Raw matrials and Excipients share the same profile but are in different bundles.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-quality-specification"},{"reference":{"reference":"ValueSet/pqcmc-chemical-structure-datafile-type-terminology"},"name":"Chemical Structure Data File Type Terminology","description":"Terminology used to qualify the information pertaining to chemical structure data file types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"PlanDefinition/a2cba634-a481-4b07-9bd4-62c7ada31e1b"},"name":"Citric acid specification Example","description":"Example raw material (Citric acid) specification for CTD 3.2.S.2.3","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-quality-specification"},{"reference":{"reference":"ValueSet/pqcmc-closure-type-terminology"},"name":"Closure Type Terminology","description":"Terminology used to qualify the information pertaining to closure types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32p10"},"name":"CMC eCTD 32P10 Document","description":"Definition for a document bundle with the CMC eCTD 32P1 profiles.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32p32"},"name":"CMC eCTD 32P32 Document","description":"Definition for a document bundle with the CMC eCTD 32P32 profiles (Product Batch Formula).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32p55"},"name":"CMC eCTD 32P55 Document","description":"Definition for a document bundle with the CMC eCTD 32P55 profile (Product Characterisation of Impurities).","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32s10"},"name":"CMC eCTD 32S10 Document","description":"Definition for a document bundle with the CMC eCTD 32S1 profiles.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32s23"},"name":"CMC eCTD 32S23 Document","description":"Definition for a document bundle with the CMC eCTD 32S23 profiles.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-32s3"},"name":"CMC eCTD 32S3 Document","description":"Definition for a document bundle with the CMC eCTD 32S3 profiles.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/cmc-ectd-document-sp4151"},"name":"CMC eCTD SP4151 Document","description":"Definition for a document bundle with the CMC eCTD SP4151 profiles.","exampleBoolean":false},{"reference":{"reference":"Bundle/bd0f0a7a-27ea-4884-801d-bd0546e80888"},"name":"CMCeCTDDocument32P10 bundle","description":"A bundle for 3.2.P.1.0","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p10"},{"reference":{"reference":"ValueSet/pqcmc-coating-purpose"},"name":"Coating Purpose Terminology","description":"A category of terminology used to qualify the information pertaining to the coating purpose in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"Composition/4bd1ed57-852b-42be-a9b0-355f8a2aa7d4"},"name":"Cochineal specification Composition Example","description":"Composition SP4151 implementing eCTD 3.2.P.4.0","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-sp4151"},{"reference":{"reference":"PlanDefinition/37bf5cc0-33bf-478b-b84e-ccb35143ef6e"},"name":"Cochineal specification Example","description":"Quality Specification for Cochineal","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-quality-specification"},{"reference":{"reference":"CodeSystem/pqcmc-comp-section-types"},"name":"Code System PQCMC Comp Section Types","description":"Classification of a section of a PQ/CMC composition/document generally based on eCTD Module 3 section numbering for product and substance. A composition can have many section codes. Codes temporarily defined as part of the PQ-CMC-FDA implementation guide.  These will eventually migrate into an officially maintained terminology (likely either NCIt or HL7's UTG code systems).","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-product-characteristic"},"name":"Code System PQCMC Product Characteristic","description":"Product Characteristic for the characteristic element in ManufacturedItemDefinition for product composition.","exampleBoolean":false},{"reference":{"reference":"Organization/4f3e9af1-306b-4fad-bf04-7881400b266a"},"name":"CodedOrganization - Wunderwerke","description":"A company sponsor of a drug application","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"Organization/49438799-e286-432c-b8d8-68ac77e7f519"},"name":"CodedOrganization J. Jones Research","description":"Example of a Sponsor type of Organization","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"StructureDefinition/pqcmc-component-substance"},"name":"Component Substance","description":"Any raw material intended for use in the manufacture of a drug substance, or any ingredient intended for use in the manufacture of a drug product including those that may not appear in such drug product.","exampleBoolean":false},{"reference":{"reference":"SubstanceDefinition/fc878c4f-a98c-427c-816b-e03ccdf0e712"},"name":"Composition ingredient substance indentifying information - acetaminophen","description":"An API used in two layer table example.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-component-substance"},{"reference":{"reference":"SubstanceDefinition/2d70d504-8cc6-4282-81d4-b20b0a98b78b"},"name":"Composition ingredient substance indentifying information - aspirin","description":"API used in two layer table example","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-component-substance"},{"reference":{"reference":"SubstanceDefinition/393a14e7-3edc-4373-bbe5-9e569d504a1c"},"name":"Composition ingredient substance indentifying information - Maize starch","description":"An excipient in the two layer tablet","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-component-substance"},{"reference":{"reference":"ValueSet/pqcmc-conformance-to-criteria-terminology"},"name":"Conformance to Criteria Terminology","description":"Terminology used to qualify the information pertaining to conformance to criteria in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-container-closure-extension"},"name":"Container Closure","description":"The packaging information including a brief description of the components, the assembled packaging system and any precautions needed to ensure the protection and preservation of the drug substance or drug product during their use in the clinical trials.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-container-type-terminology"},"name":"Container Type Terminology","description":"Terminology used to qualify the information pertaining to container types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ContainerClosure"},"name":"ContainerClosure","description":"Container Closure for drug product referred to in Drug Product Description.","exampleBoolean":false},{"reference":{"reference":"MedicinalProductDefinition/ddd3abad-347c-4d2f-95f3-dd804e250502"},"name":"ddd3abad-347c-4d2f-95f3-dd804e250502","description":"Example of Drug Product with Impurities","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-with-impurities"},{"reference":{"reference":"DocumentReference/de75e338-626c-4503-a25d-4fcdd8e39bee"},"name":"de75e338-626c-4503-a25d-4fcdd8e39bee","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-structure-reference"},{"reference":{"reference":"StructureDefinition/cmc-document-reference"},"name":"Document Reference Attachment","description":"A profile that represents the document or diagram in base64.","exampleBoolean":false},{"reference":{"reference":"Organization/e165f057-5eed-4e64-8328-4438fc88fb1b"},"name":"Drug Manufacturing Site - Vandechemie","description":"Example of Manufacturing site using the CodedOrganization profile - Vandechemie","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"StructureDefinition/pqcmc-product-batch-formula"},"name":"Drug Product Batch Formula","description":"Listing of all components of the dosage form to be used in the manufacture, their amounts on a per batch basis, including overages, and reference to their quality standards.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-dp-ingredient"},"name":"Drug Product Batch Formula Ingredient","description":"The amount details about the drug product ingredients in the batch. Use for Batch Formula.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-component"},"name":"Drug Product Component","description":"The amount details about the drug product components to define the product composition in a product unit. Use composition.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-drug-product-component-function-category-terminology"},"name":"Drug Product Component Function Category Terminology","description":"Terminology used to qualify the information pertaining to drug product component function categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drugproduct-container-closure"},"name":"Drug Product Container Closure","description":"Description and coding of the container closure system. Profile of Drug Product profile.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-description"},"name":"Drug Product Description","description":"Includes the properties of the drug product and components. Profile of Drug Product profile.","exampleBoolean":false},{"reference":{"reference":"MedicinalProductDefinition/89676a69-1fe7-422c-ab00-92abe4ef6ea9"},"name":"drug product for specification","description":"Includes the identifier of the drug product","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-handle"},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-handle"},"name":"Drug Product Handle","description":"Includes the essential identifying information of the drug product required to link to other profiles about the product in the eCTD structure.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-with-impurities"},"name":"Drug Product Impurities","description":"List of drug product impurities. Profile of Drug Product profile.","exampleBoolean":false},{"reference":{"reference":"ValueSet/spl-drug-route-of-administration-terminology"},"name":"Drug Route Of Administration Terminology","description":"Terminology used for representation of the information on pharmaceutical product route of administration in the framework of the Structured Product Labeling documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-substance-characterisation"},"name":"Drug Substance","description":"Drug Substance (Active Ingredient) nomenclature and characterisation.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-routine-drug-substance"},"name":"Drug Substance Handle","description":"Provides sufficient information to identify a drug substance. Profile on SubstanceDefinition.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-product-substance-impurity"},"name":"Drug Substance Impurity","description":"Any component of the drug substance that is not the chemical entity for procduct composition.","exampleBoolean":false},{"reference":{"reference":"SubstanceDefinition/21b6b724-507e-4cf4-a462-93334b98d166"},"name":"Drug Substance Nomenclature and Structure","description":"LEVOTHYROXINE SODIUM ANHYDROUS","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-substance-nomenclature-structure"},{"reference":{"reference":"Ingredient/d01421cc-6488-468b-a676-d3e7281875e2"},"name":"DrugProductComponent example for an excipient - Maize starch","description":"Strength is captured for all excipients","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-component"},{"reference":{"reference":"Organization/e875ef93-a730-4c44-bead-53663ae7f501"},"name":"East-West Manufacturing","description":"Manufacture of Chemicals","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"StructureDefinition/ectd-composition-32p32"},"name":"eCTD Batch Formula","description":"The fields needed to represent the Product Batch Formula to be included under the eCTD. References Sponsor Organization and Batch Formula","exampleBoolean":false},{"reference":{"reference":"Composition/260f5aa3-23d2-4999-8e5f-70f247390ee5"},"name":"eCTD Composition for 3.2.S.1","description":"Composistion containing eCTD Substance General Information ","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32s10"},{"reference":{"reference":"Bundle/7ce2088d-d281-4e2f-9a25-120a1f9805d1"},"name":"eCTD Document for 32S23","description":"This is an example of the Substance Control of Materials bundle profile. It is to submit Module 3 of CTD 3.2.S.2.3 folder content to the FDA.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32s23"},{"reference":{"reference":"Composition/55d92f43-e328-4011-bbcf-744e3afd954f"},"name":"eCTD Drug Substance Specification Composition SP4151","description":"Composition SP4151 implementing eCTD 3.2.S.4.1.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-sp4151"},{"reference":{"reference":"Composition/45ec3ebc-ec1a-4b4d-bfc4-c50edc67f2ce"},"name":"eCTD Product Characterisation of Impurities","description":"FHIR Composition for 32P55","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32p55"},{"reference":{"reference":"StructureDefinition/ectd-composition-32p55"},"name":"eCTD Product Characterisation of Impurities Composition","description":"The fields needed to represent the Product Characterisation of Impurities in a to be included under the eCTD. References Sponsor Organization and Product Characterisation of Impurities","exampleBoolean":false},{"reference":{"reference":"Composition/8a07e353-9cf6-4f27-8a30-2c2d4f439847"},"name":"eCTD Product Characterisation of Impurities Composition for TabletCoatedBeadsCoatedAll","description":"FHIR composition for CMC eCTD SP4151","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32p55"},{"reference":{"reference":"StructureDefinition/ectd-composition-32p10"},"name":"eCTD Product Description and Composition","description":"The fields needed to represent the Product Description, Container Closure and Composition of the Drug Product to be included under the 3.2.P.1 heading of the eCTD. References Sponsor Organization, Drug Product Description, and Product Container Closure System.","exampleBoolean":false},{"reference":{"reference":"Composition/d332acdf-4874-407b-9950-528f14c6bea2"},"name":"eCTD Product Specification Composition SP4151","description":"Composition SP4151 implementing eCTD 3.2.P.5.1.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-sp4151"},{"reference":{"reference":"ValueSet/cmc-comp-section-types-vs"},"name":"eCTD sections Terminology","description":"Value set of all codes in Code system PQCMC Comp Section Types for bindings that require a value set instead of the code system.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-sp4151"},"name":"eCTD Specification Composition","description":"The fields needed to represent Quality Specifications for APIs, Drug Substances, Excipients and Raw Materials.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32s3"},"name":"eCTD Substance Characterisation","description":"The fields needed to represent the Substance Structure and Impurities to be included under the 3.2.S.3 heading of the eCTD. References Sponsor Organization, Drug Substance Structure, and Drug Substance Impurities","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32s23"},"name":"eCTD Substance Control of Materials Composition","description":"The fields needed to represent the Substance Control of Materials to be included under the eCTD 3.2.S.2.3 heading. References Sponsor Organization and Drug Substance Materials.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/ectd-composition-32s10"},"name":"eCTD Substance General Information","description":"The fields needed to represent the Substance Nomenclature and Structure to be included under the 3.2.S.1 heading of the eCTD. References Sponsor Organization.","exampleBoolean":false},{"reference":{"reference":"Composition/5dfbbf17-05c0-441d-af66-7a66072f4ae4"},"name":"EctdComposition32P10 for 2 layer tablet","description":"eCTD Product Description and Composition for the two layer tablet example","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32p10"},{"reference":{"reference":"SubstanceDefinition/717d868e-6696-4ebb-adf4-63eadb3bf058"},"name":"Exampe SubstanceDefinition- ATOMOXETINE HYDROCHLORIDE","description":"Idenfiers for the subtance used in a batch formula","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-routine-drug-substance"},{"reference":{"reference":"Ingredient/1c1a2a23-1fd7-4487-9682-49877f9f9f77"},"name":"Example AtomexetineHydrochloride","description":"Batch formula drug product example Active","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-dp-ingredient"},{"reference":{"reference":"Bundle/a242b79e-b706-49d3-93ba-b4364ab2baa3"},"name":"Example Batch Formula bundle","description":"FHIR bundle with a CMC eCTD 32P32 profile","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-32p32"},{"reference":{"reference":"Composition/0003c00b-bfc2-4775-8b1c-9f99d5cf1f39"},"name":"Example Composition 3.2.P.3.2","description":"Composition 32P32 - Batch Formula Composition","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32p32"},{"reference":{"reference":"Composition/5c0d341e-6e4f-457c-811d-cfaf3eb62ecd"},"name":"Example Composition for CTD 3.2.S.2.3","description":"This composition contains one section with reference to each raw material specification for the drug substance.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32s23"},{"reference":{"reference":"PackagedProductDefinition/77ad6922-9c59-43d1-93cb-29d063cc2e8c"},"name":"Example Container Closure","description":"a plastic bottle with a child-proof cap","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ContainerClosure"},{"reference":{"reference":"Organization/d9e7c2f7-0f59-4645-bb6d-5a8dd2425049"},"name":"Example of a Supplier Organization","description":"This example if for a Supplier Organization","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"Organization/8ee60ed1-e22f-4d3b-ab08-8986e4e8e1d9"},"name":"Example of CodedOrganization profile on Organization","description":"A profile for the data elements required to identify an organization that manufactures, processes or tests drug products or substances.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"SubstanceDefinition/fd84a8b5-9e96-451c-a5c6-097c943eb38a"},"name":"Example SubstanceDefinition for anhydrous citric acid","description":"Identification of the subject of the specification. It is commonly used in the pharmaceutical industry as a stabilizer and preservative.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"SubstanceDefinition/0efb1188-04f0-44ba-bfe7-ca6169ca8703"},"name":"Example SubstanceDefinition for Carrageenan","description":"Identification of the subject of the specification which is a sourced plant based raw materials. It contains the sourceMaterial backbone elements.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"SubstanceDefinition/d3a11b25-e160-4688-b807-6383364096fd"},"name":"Example SubstanceDefinition for water","description":"Identification of the subject of the specification","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"SubstanceDefinition/580c28ac-1a2c-49fa-9be3-de997da5edcf"},"name":"Example SubstanceDefinitionHandle - IBUPROFEN","description":"Provides sufficient information to identify a drug substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-routine-drug-substance"},{"reference":{"reference":"SubstanceDefinition/cd84a8b5-4e96-551c-15c6-c97c943eb38a"},"name":"Example SubstanceDefinitionHandle for Asprin","description":"Identification of the Drug Substance of the raw materials whose specifications are for Aspirin.","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-routine-drug-substance"},{"reference":{"reference":"Ingredient/12cce82f-8595-4860-b7ca-06c9ec0327f2"},"name":"Exampple batch formula ingredient - Acetic Acid","description":"Example inactive ingredient in batch formula","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-dp-ingredient"},{"reference":{"reference":"Ingredient/29c0ee76-f62f-41d3-b761-73d5f205e552"},"name":"Exampple batch formula ingredient - Mannitol","description":"Example inactive ingredient in batch formula","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-dp-ingredient"},{"reference":{"reference":"Ingredient/44fad9fd-826a-4f0c-9f25-e0a78d1c4269"},"name":"Exampple batch formula ingredient - Metacresol","description":"Example inactive ingredient in batch formula","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-dp-ingredient"},{"reference":{"reference":"Ingredient/45eb4f05-83d9-4819-bb60-96c7c5ce2b76"},"name":"Exampple batch formula ingredient - Sodium Acetate Anhydrous","description":"Example inactive ingredient in batch formula","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-dp-ingredient"},{"reference":{"reference":"Ingredient/d0574580-7694-4a36-8a27-5bdbccfc5557"},"name":"Exampple batch formula ingredient - Water","description":"Example inactive ingredient in batch formula","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-dp-ingredient"},{"reference":{"reference":"SubstanceDefinition/45942749-64db-4f91-88c3-51adb680fed1"},"name":"Exampple batch formula ingredient substance - Acetic Acid","description":"Example inactive ingredient in batch formula. Contains the identiy and codes of the substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"SubstanceDefinition/a339a562-e325-4ce6-a830-d25c27b5e2da"},"name":"Exampple batch formula ingredient substance - MANNITOL","description":"Example inactive ingredient in batch formula. Contains the identiy and codes of the substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"SubstanceDefinition/c75df5fb-e962-43a6-9dd3-c6682da10a7e"},"name":"Exampple batch formula ingredient substance - METACRESOL","description":"Example inactive ingredient in batch formula. Contains the identiy and codes of the substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"SubstanceDefinition/07c598ee-3dcf-45b7-b4e5-b24812c22aff"},"name":"Exampple batch formula ingredient substance - Sodium Acetate Anhydrous","description":"Example inactive ingredient in batch formula. Contains the identiy and codes of the substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"SubstanceDefinition/c4e5b7c6-2e52-48e3-813b-d227cf29329b"},"name":"Exampple batch formula ingredient substance - Water","description":"Example inactive ingredient in batch formula. Contains the identiy and codes of the substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-excipient"},{"reference":{"reference":"StructureDefinition/pqcmc-excipient"},"name":"Excipient Drug Substance","description":"Provides sufficient information to identify an inactive substance and raw materials and its source when stability data is required in the submission.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-excipient-function-terminology"},"name":"Excipient Function Terminology","description":"Terminology used to qualify the information pertaining to excipient functions in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"Organization/f22ab70c-20c0-4ee4-848b-622b67ec8592"},"name":"f22ab70c-20c0-4ee4-848b-622b67ec8592","description":"Sponsor for Amphetamine Salts 32P55","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"SubstanceDefinition/ffa30c0b-8031-436a-87f1-635b3bbe5989"},"name":"ffa30c0b-8031-436a-87f1-635b3bbe5989","description":"Impurity substance - hydroxyApatite","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-product-substance-impurity"},{"reference":{"reference":"Bundle/4a7e17c1-a611-4cc7-9a71-8005a8b427ab"},"name":"FHIR Document example of 3.2.P.5.1.","description":"FHIR document bundle with the CMC eCTD SP4151 profile for a Drug Product","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-sp4151"},{"reference":{"reference":"Bundle/6004e36e-7df9-469d-9b29-8e9f9bd7e95f"},"name":"FHIR Document example of 3.2.S.4.1.","description":"FHIR document bundle with the CMC eCTD SP4151 profile for a Drug Substance","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-ectd-document-sp4151"},{"reference":{"reference":"StructureDefinition/pqcmc-graphic-reference"},"name":"Graphic Reference","description":"A Document Reference to any attachment tha contains a graphical representation","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-graphical-file-types"},"name":"Graphical File Types","description":"The acceptable file types that can be used in graphical files","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-hierarchical-level-extension"},"name":"Hierarchical Level","description":"Numeric level in the hierarchical value-set","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-impurity-classification-terminology"},"name":"Impurity Classification Terminology","description":"Terminology used to qualify the information pertaining to impurity classifications in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"SubstanceDefinition/496f83ad-2365-4b12-8672-a349d99f7d67"},"name":"IngredComponentSubstance example showing the use of the sourceMaterial backbone element","description":"ComponentSubstance example showing the use use of the sourceMaterial backbone element","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-component-substance"},{"reference":{"reference":"ValueSet/pqcmc-product-part-ingredient-physical-location"},"name":"Ingredient Location Terminology","description":"A category of terminology used to qualify the information pertaining to the location of an ingredient within a product in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-manufactured-dose-form-terminology"},"name":"Manufactured Dose Form Terminology","description":"Terminology used to qualify the information pertaining to the manufactured dose form.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-product-part"},"name":"Manufactured Drug Product","description":"The manufactured drug product defined by all its parts or layers. If the drug product composition is homogeneous it will have a single part or component.","exampleBoolean":false},{"reference":{"reference":"Organization/4b565cf3-5353-48af-8cd6-5ccf4e9fd579"},"name":"Manufacturing Site (J. Jones Research)","description":"Manufacturing site instance of an Organization Example. There will be a type code in future","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"ValueSet/pqcmc-name-part-terminology"},"name":"Name Part Terminology","description":"Terminology used to qualify the information pertaining to Name Part data in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-non-percentage-units"},"name":"Non-Percentage Units","description":"Units of Measure terminologies that do not represent percentages","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-org-identifier-type-terminology"},"name":"Organization-Site Identifier Terminology","description":"Terminology used to qualify the information pertaining to the sponsor or testing site unique identifier types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-percentage-units"},"name":"Percentage Units","description":"Units of Measure terminologies that represent the concept of a percentage","exampleBoolean":false},{"reference":{"reference":"ValueSet/spl-pharmaceutical-dosage-form-terminology"},"name":"Pharmaceutical Dosage Form Terminology","description":"Terminology used for representation of the information on pharmaceutical product dosage form in the framework of the SPL documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-polymorphic-form"},"name":"Polymorphic Form","description":"Alternate structure present in the drug substance","exampleBoolean":false},{"reference":{"reference":"SubstanceDefinition/832f22b4-6f0c-41f8-9b7d-f26f55e9973c"},"name":"Polymorphic Form Example","description":"Polymorphic Form - DextroThyroxine","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-polymorphic-form"},{"reference":{"reference":"CodeSystem/cmc-ncit-dummy"},"name":"PQ-CMC-FDA Temporary Codes","description":"Codes are temporarily defined as part of the PQ-CMC-FDA implementation guide.  Some but not all are defined in NCIt. When all codes are in NCIt, they will migrate to the HL7 Terminology (THO). Note: Codes that exist in NCIt at time of ballot begin with 'C'.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-cmc-address"},"name":"PqAddress","description":"pq-specific Constraints on the Address datatype dealing with US addresses.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-attachment"},"name":"PQCMC Attachment","description":"Any attached file in a submission is required to have a type, data, and a title","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-product-batch-ingredient-extension"},"name":"Product Batch Ingredient Extension","description":"Extension for measurement properties for ingredients in the batch formla.","exampleBoolean":false},{"reference":{"reference":"CodeSystem/cmc-product-name-types"},"name":"Product Name Types Code Types","description":"Indicates patent or trademark status. Codes temporarily defined as part of the PQ-CMC-FDA implementation guide.  These will eventually migrate into an officially maintained terminology (likely either NCIt or HL7's UTG code systems)","exampleBoolean":false},{"reference":{"reference":"ValueSet/cmc-product-name-types-vs"},"name":"Product Name Types Terminology","description":"Local value set of all codes in the Code system.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-product-part-type"},"name":"Product Part Type Terminology","description":"A category of terminology used to qualify the information pertaining to the product part type in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-quality-benchmark-terminology"},"name":"Quality Benchmark Terminology","description":"Terminology used to qualify the information pertaining to quality benchmarks in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-quality-specification"},"name":"Quality Specification","description":"A quality specification is for a drug product or drug substance (excipient, API or raw material).","exampleBoolean":false},{"reference":{"reference":"CodeSystem/cmc-relationship-types"},"name":"Relationship Types Codes","description":"Local value set of all codes in the Relationship Types code system.Codes temporarily defined as part of the PQ-CMC-FDA implementation guide.  These will eventually migrate into an officially maintained terminology (likely either NCIt or HL7's UTG code systems)","exampleBoolean":false},{"reference":{"reference":"ValueSet/cmc-relationship-types-vs"},"name":"Relationship Types Terminology","description":"Local value set of all codes in Relationship Types codes","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-release-mechanism"},"name":"Release Mechanism Terminology","description":"A category of terminology used to qualify the information pertaining to release mechanism in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-release-profile"},"name":"Release Profile Terminology","description":"A category of terminology used to qualify the information pertaining to release profile in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-source-type-terminology"},"name":"Source Type Terminology","description":"Terminology used to qualify the information pertaining to source types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-specification-status-extension"},"name":"Specification Status","description":"A classification of the regulatory status of the specification.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-specification-status-terminology"},"name":"Specification Status Terminology","description":"Terminology used to qualify the information pertaining to specification statuses in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/cmc-specification-types-vs"},"name":"Specification Type Terminology","description":"Local value set of all codes in Specification Type codes","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-specification-type-terminology"},"name":"Specification Type Terminology","description":"Terminology used to qualify the information pertaining to specification types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"Organization/b69435a0-45c6-4d44-9fde-b354e17408d7"},"name":"Sponsor of API","description":"CodedOrganization - Large Life","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"StructureDefinition/strength-extension"},"name":"Strength Extension","description":"Strength Type (for API)","exampleBoolean":false},{"reference":{"reference":"Ingredient/fc09842a-8f71-48f2-9f9f-ff2441b2eb6f"},"name":"Strength info for the Active Ingredient","description":"one of the active ingredients in the two layer table example - aspirin","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-component"},{"reference":{"reference":"Ingredient/3791c4ce-2b43-4d7b-b195-0e5f88f28dab"},"name":"Strength information - Grape skin extract","description":"Example of a DrugProductComponent for an Inactive Ingredient","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-component"},{"reference":{"reference":"Ingredient/7f10a35e-228d-42db-8918-6ccada78454d"},"name":"Strength information for the Active Ingredient - acetaminophen","description":"An active ingredient in the two layer table example -  acetaminophen","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-component"},{"reference":{"reference":"ValueSet/pqcmc-strength-type-terminology"},"name":"Strength Type Terminology","description":"Terminology used to qualify the information pertaining to strength types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-structure-data"},"name":"Structure Data","description":"Any attached file that contains structure data (e.g. SDFiles, MolFiles, INCHI)","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-structure-reference"},"name":"Structure Data Reference","description":"A Document Reference to any attachment that contains structure data","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-structure-data-types"},"name":"Structure Data Types","description":"The acceptable file types that can be used in Structure Data Files (MOL,SDF,INCHI,etc)","exampleBoolean":false},{"reference":{"reference":"SubstanceDefinition/3419cdae-4d99-4068-bfaa-8037550bf327"},"name":"Substance Characterization - EthylAcetate","description":"Drug Substance Characterization for EthylAcetate","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-drug-substance-characterisation"},{"reference":{"reference":"Composition/d52acdbd-6881-495a-84a2-0dccf07ee5ab"},"name":"Substance Characterization for EthylAcetate","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32s3"},{"reference":{"reference":"ValueSet/substance-classification"},"name":"Substance Classification","description":"Substance classes","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pqcmc-drug-substance-nomenclature-structure"},"name":"Substance General Information","description":"Substance General Information containting Drug Substance (Active Ingredient) nomenclature (2.3.S.1.1) and Substance Structure (2.3.S.1.2) profile.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-substance-name-type"},"name":"Substance Name Type","description":"A category of terminology used to quality the information pertaining to the type of substance name in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"StructureDefinition/pq-target-range"},"name":"Target Range","description":"The FHIR Range datatype uses Simple Quantities to represent the high and low bounds, which do not allow a comparator to be set. This extension allows the high and low bounds to have a comparator","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-test-category-terminology"},"name":"Test Category Terminology","description":"Terminology used to qualify the information pertaining to test categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-test-method-origin-terminology"},"name":"Test Method Origin Terminology","description":"Terminology used to qualify the information pertaining to test method origins in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-test-usage-terminology"},"name":"Test Usage Terminology","description":"Terminology used to qualify the information pertaining to test usage in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.","exampleBoolean":false},{"reference":{"reference":"ValueSet/pqcmc-units-of-measure-terminology"},"name":"Units Of Measure Terminology","description":"Terminology used to qualify the information pertaining to units of measure in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.\r\nNote: Includes SPL Unit of Presentation Terminology","exampleBoolean":false},{"reference":{"reference":"Organization/e99bddfa-c1b5-435b-bbe8-24816b4e23e5"},"name":"Vidinaid","description":"Manufacturing site (Vidinaid) instance with second address line","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/cmc-organization"},{"reference":{"reference":"PlanDefinition/5819b223-d3d2-419f-b617-b3a9a3625b89"},"name":"Water Specification Example","description":"Example raw material (water) specification for CTD 3.2.S.2.3","exampleCanonical":"http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/pqcmc-quality-specification"}],"page":{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"toc.html"}],"nameUrl":"toc.html","title":"Table of Contents","generation":"html","page":[{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"index.html"}],"nameUrl":"index.html","title":"Home","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"instruction.html"}],"nameUrl":"instruction.html","title":"General Instructions","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32S10.html"}],"nameUrl":"eCTD32S10.html","title":"General Information (3.2.S.1)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32S23.html"}],"nameUrl":"eCTD32S23.html","title":"Substance Control of Materials (3.2.S.2.3)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32S3.html"}],"nameUrl":"eCTD32S3.html","title":"eCTD Substance Characterisation (3.2.S.3)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTDSP4151.html"}],"nameUrl":"eCTDSP4151.html","title":"Specification (3.2.S.4.1, 3.2.P.4 and 3.2.P.5.1)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32P10.html"}],"nameUrl":"eCTD32P10.html","title":"Description and Composition of the Drug Product (3.2.P.1)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32P32.html"}],"nameUrl":"eCTD32P32.html","title":"Product Batch Formula (3.2.P.3.2)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"eCTD32P55.html"}],"nameUrl":"eCTD32P55.html","title":"Product Characterisation of Impurities (3.2.P.5.5)","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"artifacts.html"}],"nameUrl":"artifacts.html","title":"Artifact List","generation":"html"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"downloads.html"}],"nameUrl":"downloads.html","title":"Downloads","generation":"markdown"},{"extension":[{"url":"http://hl7.org/fhir/tools/StructureDefinition/ig-page-name","valueUrl":"change_notes.html"}],"nameUrl":"change_notes.html","title":"Change Notes","generation":"markdown"}]},"parameter":[{"code":"copyrightyear","value":"2021+"},{"code":"releaselabel","value":"Reconciliation + Stage 2"},{"code":"releaselabel","value":"true"},{"code":"excludettl","value":"true"},{"code":"excludemap","value":"true"},{"code":"apply-wg","value":"true"},{"code":"jira-code","value":"pq-cmc"},{"code":"auto-oid-root","value":"2.16.840.1.113883.4.642.40.36"},{"code":"special-url","value":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl - https://www.uniprot.org - urn:oid:1.3.6.1.4.1.5193 - http://unitsofmeasure.org - urn:oid:1.3.6.1.4.1.519.1 - urn:oid:2.16.840.1.113883.4.82 - https://www.fda.gov/drugs/drug-approvals-and-databases/drug-establishments-current-registration-site - urn:ietf:rfc:3986"},{"code":"path-history","value":"http://hl7.org/fhir/us/pq-cmc-fda/history.html"}]}}
